As we hypothesized that the majority of TNC+ EVs observedin the peripheral blood of glioblastoma patients are released fromTNChigh tumor cells, we sought to also quantify TNC inEVs derived from tumor tissues. The gene discussed is TNC; the disease is neoplasm.